Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1998 1
1999 1
2000 3
2001 4
2002 2
2004 3
2005 3
2006 3
2007 2
2008 4
2009 3
2010 8
2011 5
2012 4
2013 3
2014 4
2015 6
2016 4
2017 6
2018 11
2019 4
2020 5
2021 11
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 27581820

99 results

Results by year

Filters applied: . Clear all
Page 1
European perspectives on hyperkinetic disorder.
Sergeant J, Steinhausen HC. Sergeant J, et al. Eur Child Adolesc Psychiatry. 1992 Jan;1(1):34-41. doi: 10.1007/BF02084432. Eur Child Adolesc Psychiatry. 1992. PMID: 29871402
Adding noise is a confounded nuisance.
Francis AL. Francis AL. J Acoust Soc Am. 2022 Sep;152(3):1375. doi: 10.1121/10.0013874. J Acoust Soc Am. 2022. PMID: 36182286
Policy Guidelines for Effective Inclusion and Reintegration of People with Chronic Diseases in the Workplace: National and European Perspectives.
Vlachou A, Stavroussi P, Roka O, Vasilou E, Papadimitriou D, Scaratti C, Kadyrbaeva A, Fheodoroff K, Brecelj V, Svestkova O, Tobiasz-Adamczyk B, Finnvold JE, Gruber S, Leonardi M. Vlachou A, et al. Int J Environ Res Public Health. 2018 Mar 11;15(3):493. doi: 10.3390/ijerph15030493. Int J Environ Res Public Health. 2018. PMID: 29534484 Free PMC article.
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
Li X, Bilcke J, van der Velden AW, Bruyndonckx R, Coenen S, Bongard E, de Paor M, Chlabicz S, Godycki-Cwirko M, Francis N, Aabenhus R, Bucher HC, Colliers A, De Sutter A, Garcia-Sangenis A, Glinz D, Harbin NJ, Kosiek K, Lindbæk M, Lionis C, Llor C, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Sundvall PD, Touboul Lundgren P, Tsakountakis N, Verheij TJ, Goossens H, Butler CC, Beutels P; ALIC4Etrial investigators. Li X, et al. Eur J Health Econ. 2023 Aug;24(6):909-922. doi: 10.1007/s10198-022-01521-2. Epub 2022 Sep 22. Eur J Health Econ. 2023. PMID: 36131214 Free PMC article.
99 results